Additions from Clifford Chance, Mayer Brown, Akin and Freshfields headlined a week that also included an M&A hire for Paul Weiss and Cleary’s hire of a PE-focused debt finance partner
Tom Schoors will combine the new EU chair role with his post as Belgium managing partner, helping global clients to tap into the firm’s EU expertise across 16 offices
Maria Tan Pedersen, co-head of the firm’s emerging markets product line, discusses market trends and how gender diversity can help tip the balance in panel appointments
Partners at Hogan Lovells Hong Kong, Allen & Gledhill Singapore, and Baker McKenzie Japan share insights on the 2026 outlook for private credit market in the APAC region
On 21 November 2024, the National Assembly officially passed Law No. 44/2024/QH15, amending and supplementing certain provisions of the Law on Pharmaceuticals 2016 (“2024 Law Amendment”). The 2024 Law Amendment is a key step in modernizing Vietnam’s pharmaceutical regulations.
The Government has issued Decree 70/2025/ND-CP (“Decree 70”), amending and supplementing certain provisions of Decree 123/2020/ND-CP on invoices and invoicing. Decree 70 takes effect on 1 June 2025.
In just the past few months, Vietnam has enacted a wave of landmark laws, decrees, and government resolutions – signalling a bold and determined push by the nation’s leadership to reshape its legal landscape.
